Pharmacokinetics
Phase Ib PK data showed rapid absorption (1–3 h) and elimination of galunisertib within 48 h. Observed galunisertib plasma concentrations were comparable with those observed in previous galunisertib trials [There was no significant immunogenicity observed that would have impacted study results.